Lysol Maker Reckitt Issues New $664 Million Share Buyback

By Aimee Look


Lysol maker Reckitt Benckiser issued a new share buyback program after reporting growing like-for-like net revenue in the second quarter.

Reckitt, which counts cold medication Mucinex and Durex condoms among its brands, said it would repurchase up to 500 million pounds ($664.5 million) in shares over the next twelve months through a new share buyback program.

The buyback comes as the U.K. consumer-goods company undergoes a broad strategic revamp through pending and completed disposals.

Second-quarter revenue grew 4.7% on a like-for-like basis to 3.17 billion pounds, compared with analyst expectations of a 3.6% increase.

For the first half, group adjusted operating profit--which strips out exceptional and other one-off items-fell 14.3% on year to 1.47 billion pounds. Analysts had forecast 1.39 billion pounds for the metric, according to company-compiled estimates.

The company also booked pretax profit of 981 million pounds for the first six months of the year compared with 1.31 billion pounds a year prior.

Reckitt backed its guidance for 2026 of like-for-like growth for net revenue in its core business of 4% to 5%.


Write to Aimee Look at aimee.look@wsj.com


(END) Dow Jones Newswires

July 29, 2026 02:41 ET (06:41 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center